Profile data is unavailable for this security.
About the company
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
- Revenue in USD (TTM)0.00
- Net income in USD-55.09m
- Incorporated2003
- Employees47.00
- LocationMilestone Pharmaceuticals Inc420-1111 boul. Dr.-Frederik-PhilipsMONTREAL H4M 2X6CanadaCAN
- Phone+1 (514) 336-0444
- Fax+1 (514) 336-0444
- Websitehttps://www.milestonepharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bakhu Holdings Corp | 0.00 | -1.92m | 75.33m | 2.00 | -- | -- | -- | -- | -0.0064 | -0.0064 | 0.00 | -0.0325 | 0.00 | -- | -- | 0.00 | -281.75 | -4,391.82 | -- | -- | -- | -- | -- | -- | -- | -8.39 | -- | -- | -- | -- | 33.37 | -- | -- | -- |
Tempest Therapeutics Inc | 0.00 | -29.76m | 75.76m | 17.00 | -- | 3.67 | -- | -- | -1.76 | -1.76 | 0.00 | 0.9287 | 0.00 | -- | -- | 0.00 | -72.84 | -57.10 | -93.72 | -71.20 | -- | -- | -- | -- | -- | -141.39 | 0.3394 | -- | -- | -- | 17.41 | -- | 36.40 | -- |
Cognition Therapeutics Inc | 0.00 | -28.77m | 76.11m | 25.00 | -- | 2.63 | -- | -- | -0.9155 | -0.9155 | 0.00 | 0.7218 | 0.00 | -- | -- | 0.00 | -68.08 | -- | -85.18 | -- | -- | -- | -- | -- | -- | -251.59 | 0.00 | -- | -- | -- | -20.52 | -- | -- | -- |
Personalis Inc | 74.15m | -92.61m | 76.35m | 223.00 | -- | 0.626 | -- | 1.03 | -1.89 | -1.89 | 1.51 | 2.35 | 0.3172 | 6.50 | 5.04 | 332,493.30 | -39.62 | -28.84 | -46.08 | -34.72 | 25.59 | 28.65 | -124.90 | -96.01 | 3.56 | -- | 0.0209 | -- | 12.97 | 14.23 | 4.43 | -- | 6.80 | -- |
Serina Therapeutics Inc | 137.00k | -20.96m | 76.48m | 4.00 | -- | -- | -- | 558.26 | -14.07 | -14.07 | 0.0909 | -0.5121 | 0.0117 | -- | 3.86 | 34,250.00 | -179.27 | -194.46 | -- | -- | 67.88 | 85.80 | -15,301.46 | -2,347.36 | -- | -0.9274 | 1.70 | -- | 317.65 | -36.69 | -41.49 | -- | -- | -- |
Passage Bio Inc | 0.00 | -84.44m | 77.67m | 58.00 | -- | 0.7402 | -- | -- | -1.53 | -1.53 | 0.00 | 1.70 | 0.00 | -- | -- | 0.00 | -47.73 | -48.56 | -52.17 | -52.09 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 25.02 | -- | -43.53 | -- |
Spero Therapeutics Inc | 110.98m | 23.40m | 78.28m | 46.00 | 3.44 | 0.8115 | 3.30 | 0.7054 | 0.4213 | 0.4213 | 2.08 | 1.79 | 0.792 | -- | 3.96 | 2,412,565.00 | 16.70 | -35.52 | 21.73 | -41.75 | -- | -- | 21.09 | -124.40 | -- | -- | 0.00 | -- | 93.95 | 92.11 | 149.14 | -- | -- | -- |
MDxHealth SA - ADR | 75.33m | -39.90m | 78.81m | 300.00 | -- | -- | -- | 1.05 | -1.14 | -1.14 | 0.8428 | -0.0357 | 0.5528 | 11.06 | 6.95 | 251,090.00 | -29.28 | -51.62 | -33.98 | -64.72 | 62.76 | 50.88 | -52.97 | -117.64 | 1.53 | -1.54 | 1.02 | -- | 89.43 | 19.84 | 2.14 | -- | 30.13 | -- |
Milestone Pharmaceuticals Inc | 0.00 | -55.09m | 78.83m | 47.00 | -- | 1.97 | -- | -- | -1.25 | -1.25 | 0.00 | 0.7498 | 0.00 | -- | -- | 0.00 | -53.21 | -48.44 | -56.51 | -51.56 | -- | -- | -- | -1,267.25 | -- | -- | 0.5592 | -- | -80.00 | -- | -2.22 | -- | 86.23 | -- |
IO Biotech Inc | 0.00 | -88.50m | 79.72m | 68.00 | -- | 0.6904 | -- | -- | -1.86 | -1.86 | 0.00 | 1.75 | 0.00 | -- | -- | 0.00 | -66.79 | -- | -72.66 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -20.47 | -- | -- | -- |
Anixa Biosciences Inc | 210.00k | -10.74m | 79.75m | 4.00 | -- | 3.23 | -- | 379.76 | -0.3451 | -0.3451 | 0.0068 | 0.7749 | 0.0078 | -- | 0.7807 | 52,500.00 | -40.49 | -59.69 | -41.26 | -62.61 | -- | -- | -5,174.29 | -6,040.10 | -- | -- | 0.00 | -- | -- | -28.36 | 27.83 | -- | -- | -- |
Cue Biopharma Inc | 7.02m | -49.97m | 80.26m | 53.00 | -- | 2.67 | -- | 11.43 | -1.07 | -1.07 | 0.1495 | 0.6175 | 0.1035 | -- | 8.80 | 132,452.80 | -73.69 | -57.45 | -96.35 | -68.41 | -- | -- | -711.84 | -810.87 | -- | -- | 0.1935 | -- | 340.88 | 36.88 | 4.30 | -- | -- | -- |
Elutia Inc | 25.05m | -49.46m | 81.40m | 54.00 | -- | -- | -- | 3.25 | -2.35 | -2.34 | 1.24 | -2.07 | 0.5219 | 2.06 | 4.27 | 463,833.30 | -103.05 | -42.93 | -599.50 | -79.34 | 42.01 | 43.32 | -197.48 | -64.16 | 0.5499 | -1.36 | -- | -- | -49.69 | -8.71 | -25.39 | -- | 12.74 | -- |
Angion Biomedica Corp | 0.00 | -38.99m | 81.96m | 32.00 | -- | 16.75 | -- | -- | -6.63 | -6.63 | 0.00 | 0.4765 | 0.00 | -- | -- | 0.00 | -117.72 | -105.91 | -133.85 | -331.69 | -- | -- | -- | -712.81 | -- | -- | 0.00 | -- | -100.00 | -- | 9.31 | -- | -- | -- |
Data as of Jun 07 2024. Currency figures normalised to Milestone Pharmaceuticals Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
BlackRock Financial Management, Inc.as of 31 Mar 2024 | 4.71m | 8.86% |
RTW Investments LPas of 31 Mar 2024 | 3.26m | 6.13% |
Millennium Management LLCas of 31 Mar 2024 | 2.86m | 5.37% |
Alta Fundamental Advisers LLCas of 31 Mar 2024 | 2.37m | 4.46% |
Lion Point Capital LPas of 31 Mar 2024 | 2.30m | 4.33% |
Citadel Advisors LLCas of 31 Mar 2024 | 2.25m | 4.24% |
Nantahala Capital Management LLCas of 31 Mar 2024 | 1.75m | 3.29% |
Stonepine Capital Management LLCas of 31 Mar 2024 | 1.46m | 2.75% |
Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 1.35m | 2.55% |
Bleichroeder LPas of 31 Mar 2024 | 1.33m | 2.50% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.